Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Cancer Letters|May 9, 2000
Evidence for microsatellite instability in bilateral breast carcinomasE N Imyanitov, A V Togo, E N Suspitsin, et al.European Journal of Cancer (Oxford, England : 1990)|September 3, 2002
Distinct prevalence of the CYP19 Delta3(TTTA)(7) allele in premenopausal versus postmenopausal breast cancer patients, but not in control individualsE N Suspitsin, M Y Grigoriev, A V Togo, et al.Voprosy Onkologii|January 1, 1996
[Correlation between int-2 oncogene amplification and increased tumor size in breast cancer]O I Chernitsa, O I Laur, E N Imianitov, et al.Voprosy Onkologii|January 18, 2003
[Genetic polymorphism of steroid 17 alpha-hydroxylase/17,20-lyase (CYP17) and hyperinsulinemia in endometrial carcinoma]L M Berstein, E N Imianitov, V B Gamaiunova, et al.Neoplasma|October 19, 2018
PCR-based detection of EGFR, ALK, KRAS and BRAF mutations in Russian patients with lung adenocarcinoma: a single-center experienceN V Mitiushkina, M M Kholmatov, A R Venina, et al.Voprosy Onkologii|September 8, 2000
[A polymorphism study of the CYP19 gene in endometrial cancer patients]L M Bershteĭn, E N Imianitov, E N Suspitsyn, et al.Voprosy Onkologii|April 6, 2010
[Effectiveness of gefitinib (Iressa) as first-line therapy for inoperable non-small-cell lung cancer with mutated EGFR gene (phase II study)]V M Moiseenko, S A Protsenko, I I Semenov, et al.Voprosy Onkologii|August 15, 2012
[Pharmacoeconomic analysis of gefitinib therapy in patients with non-cell cell lung cancer]S A Protsenko, A V Rudakova, F V Moiseenko, et al.Voprosy Onkologii|June 5, 2004
[Allelic distribution of the CYP1A1 in lung cancer patients, middle-aged tissue donors and in elderly people without cancer]E V Belogubova, A V Togo, I K Suvorova, et al.Clinical Genetics|February 7, 2018
Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignanciesG A Yanus, T A Akhapkina, A O Ivantsov, et al.Pageof 4